Literature DB >> 2211004

The A-wave of the human electroretinogram and rod receptor function.

D C Hood1, D G Birch.   

Abstract

The amplitude of the leading edge of the a-wave of the human electroretinogram (ERG) was compared with predictions from a computational model of the light-induced responses of rod mammalian receptors. According to this model, a linear process describes the amplitude and time course of the response to relatively low flash intensities and at brief times after the onset of the flash. At higher flash intensities, a nonlinear process, described by the Naka-Rushton function or a saturating exponential, is involved. The primary focus here is on intensity-response data recorded with a clinical ganzfeld apparatus. The leading edge of the rod a-wave recorded from normal observers and patients with congenital stationary night blindness (CSNB) was described by a linear process for flash intensities up to the maximum available flash intensity, 2.0 log scot td-sec. This finding is consistent with the model of the rod's response. It suggests, however, that when ERGs are recorded with clinical systems limited to 2.0 log scot td-sec, these data cannot be used to distinguish between changes in the parameters (eg, semisaturation intensity versus maximum response) of the human rod receptors. Responses to flash intensities up to 3.4 log scot td-sec were recorded using a custom, high-intensity ganzfeld system. Both the linear and nonlinear components of the model were needed to fit the ERGs recorded with this system. This suggests that changes in different receptor parameters can be distinguished with higher intensity flashes.

Entities:  

Mesh:

Year:  1990        PMID: 2211004

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Electroretinographic determination of human rod flash response in vivo.

Authors:  D R Pepperberg; D G Birch; D C Hood
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Development of receptoral responses in pigmented and albino guinea-pigs (Cavia porcellus).

Authors:  B V Bui; A J Vingrys
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

3.  A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors.

Authors:  T D Lamb; E N Pugh
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

4.  Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram.

Authors:  C Friedburg; C P Allen; P J Mason; T D Lamb
Journal:  J Physiol       Date:  2004-02-27       Impact factor: 5.182

5.  Signal processing techniques for oscillatory potential extraction in the electroretinogram: automated highpass cutoff frequency estimation.

Authors:  John Meklenburg; Edward A Clancy; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2012-07-10       Impact factor: 2.379

Review 6.  An overview of drug development with special emphasis on the role of visual electrophysiological testing.

Authors:  Mitchell Brigell; Cun-Jian Dong; Serge Rosolen; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

7.  Empiric limits of rod photocurrent component underlying a-wave response in the electroretinogram.

Authors:  M E Breton; D P Montzka
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

8.  A(max) is the best a-wave measure for classifying Abyssinian cat rod/cone dystrophy.

Authors:  Kristina Narfström
Journal:  Doc Ophthalmol       Date:  2006-02-25       Impact factor: 2.379

9.  Amax to scotopic Imax diagnoses feline hereditary rod cone degeneration more efficiently than any other combination of long protocol electroretinogram parameters.

Authors:  Kristina Narfström
Journal:  Doc Ophthalmol       Date:  2008-01-10       Impact factor: 2.379

10.  Contribution of voltage-gated sodium channels to the b-wave of the mammalian flash electroretinogram.

Authors:  Deb Kumar Mojumder; David M Sherry; Laura J Frishman
Journal:  J Physiol       Date:  2008-04-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.